News & Opinion

» genetics & genomics, techniques and cancer

Covering the life sciences inside and out

Most Recent

image: Enzyme Improves CRISPR

Enzyme Improves CRISPR

By | April 1, 2015

A smaller Cas9 protein enables in vivo genome engineering via viral vectors.

0 Comments

image: Opinion: Upgrading Cancer Prevention

Opinion: Upgrading Cancer Prevention

By | April 1, 2015

A smaller Cas9 protein enables in vivo genome engineering via viral vectors.

1 Comment

image: Hiding in Plain Sight

Hiding in Plain Sight

By | March 31, 2015

A smaller Cas9 protein enables in vivo genome engineering via viral vectors.

1 Comment

image: Opinion: Making Cancer Vaccines Work

Opinion: Making Cancer Vaccines Work

By | March 31, 2015

A smaller Cas9 protein enables in vivo genome engineering via viral vectors.

4 Comments

image: Horizontal Gene Transfer a Hallmark of Animal Genomes?

Horizontal Gene Transfer a Hallmark of Animal Genomes?

By | March 12, 2015

A smaller Cas9 protein enables in vivo genome engineering via viral vectors.

4 Comments

image: Stimulating Neurons with Light and Gold

Stimulating Neurons with Light and Gold

By | March 12, 2015

A smaller Cas9 protein enables in vivo genome engineering via viral vectors.

0 Comments

image: Genome Digest

Genome Digest

By | March 4, 2015

A smaller Cas9 protein enables in vivo genome engineering via viral vectors.

0 Comments

image: Evolutionary Rewiring

Evolutionary Rewiring

By | February 26, 2015

A smaller Cas9 protein enables in vivo genome engineering via viral vectors.

6 Comments

image: Engineered Biomarkers Could ID Cancer Cells

Engineered Biomarkers Could ID Cancer Cells

By | February 23, 2015

A smaller Cas9 protein enables in vivo genome engineering via viral vectors.

2 Comments

image: Exploring the Epigenome

Exploring the Epigenome

By | February 18, 2015

A smaller Cas9 protein enables in vivo genome engineering via viral vectors.

2 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech